You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 293 No. 3, January 19, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Health Policy
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Perspective on US Drug Reimportation

Niteesh K. Choudhry, MD, FRCPC; Allan S. Detsky, MD, PhD, FRCPC

JAMA. 2005;293:358-362.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The high cost of prescription drugs in the United States receives media attention almost daily. In the past year, one third of Americans say that they or a family member has had difficulty paying for medications.1 A similar proportion has not filled a prescription or has reduced a prescribed dosage because of high out-of-pocket costs.2 In response, Americans are turning to cheaper sources for their prescription drugs.3 Canadian pharmacies are a logical choice because, partially as a result of governmental controls, prices for many of the most widely used drugs are substantially lower in Canada.4 A recent survey of US consumers found that 7% have purchased medications from pharmacies in Canada or another country and 16% of individuals with annual out-of-pocket drug expenditures over $1000 have done so.5 Moreover, 73% of Americans older than 50 years would consider buying . . . [Full Text of this Article]

Safety First

Author Affiliations: Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital and Harvard Medical School, and the Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Mass (Dr Choudhry); the Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto, and the Department of Medicine, Mount Sinai Hospital and University Health Network, Toronto, Ontario (Dr Detsky).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Risks and Benefits of Importing Prescription Medications From Lower-Income Countries
Dhalla and Detsky
JAMA 2008;300:1453-1455.
FULL TEXT  

Health Economists' Views of Health Policy
Morrisey and Cawley
Journal of Health Politics, Policy and Law 2008;33:707-724.
ABSTRACT  

The International Pharmaceutical Market as a Source of Low-Cost Prescription Drugs for U.S. Patients
Kesselheim and Choudhry
ANN INTERN MED 2008;148:614-619.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.